Hakam Asaad, MD
Neuromuscular Medicine · Dallas, TXNPI 1871603241
Payments from drug & device makers
Across 408 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Genentech USA, Inc.$801
- Jazz Pharmaceuticals Inc.$417
- UCB, Inc.$400
- Biogen$350
- Grifols USA, LLC$289
- plus $5K from 49 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
Too few neuromuscular medicine providers in Texasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neuromuscular medicine in Dallas
- Niloofar YariDallas$32K
- Yessar HussainAustin$6.5M
- Suur BilicilerHouston$1.5M
- Ratna Bhavaraju SankaSan Antonio$1.1M
- Matthew WicklundSan Antonio$258K
- Ashley AndersonHouston$76K
- Darine KassarSugar Land$14K
- Anita MadanHouston$3K
- George CreelTemple$3K
- Cassie ChanSan Antonio$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.